Robichaud Albert 4
4 · Sage Therapeutics, Inc. · Filed Jul 29, 2019
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Common Stock
2019-07-25+1,900→ 96,205 total - Gift
Common Stock
2019-01-11−825→ 94,137 total - Tax Payment
Common Stock
2019-07-25$161.38/sh−548$88,436→ 95,657 total
Footnotes (2)
- [F1]On February 13, 2019, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 9,500 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on July 25, 2019, resulting in the vesting of the PSU as to 1,900 shares.
- [F2]Reflects beneficial ownership balance which includes 168 ESPP shares purchased on June 30, 2019.